Science - USA (2022-06-03)

(Antfer) #1

precipitated the tRNA and protein. The super-
natant was subjected to LCMS analysis and we
detected a peak at m/z 576.1331 Da (Fig. 4, D
and E), consistent with the expected proto-
nated ML901-Tyr ion, and confirmed with
the synthetic ML901-Tyr standard (fig. S12, A to
C). Under the conditions used,Pf YRS gen-
erates more ML901-Tyr than thePf YRSS234C
dimer (fig. S12E), and no ML901-Tyr was de-
tected whenHsYRS was incubated with ML901
and the substrates, ATP, Tyr andHstRNATyr.
Thus, it appears that the ability ofPf YRS to
catalyze formation of the ML901-Tyr conjugate
is the primary factor controlling selectivity ver-
sus HsYRS and potency versusPf YRSS234C.


A structured loop over thePfYRS active site
facilitates reaction hijacking


To obtain crystals of ML901-Tyr–boundPf YRS,
we incubated His-taggedPf YRS with tyrosine,
ATP, and ML901 in the presence of tRNA and
then purified the complex by nickel affinity
and gel filtration chromatography. The crystal
structure (refined at 2.15-Å resolution) revealed
a homodimer organization (Fig. 5A and fig.
S13A) with clear density for the ML901-Tyr
ligand.


Pf YRS is a Class I aaRS characterized by a
catalytic domain that adopts a Rossmann fold
(residues 18 to 260) linked to a C-terminal
domain (residues 261 to 370) involved in rec-
ognition of the anticodon stem of tRNATyr.
Pf YRS contains the two motifs characteristic
of the catalytic domain of Class I (subclass c)
tRNA synthetases:“HIGH”and“KMSKS”
( 70 HIAQ 73 and 247 KMSKS 251 in Pf YRS). The over-
all structure of the ML901-Tyr/Pf YRS complex is
very similar to our structure ofPf YRS with the
native ligand AMP-Tyr (fig. S14 and table S8)
and the previously published structure ( 19 ).
ML901-Tyr forms multiple noncovalent inter-
actions with active site residues, involving the
pyrazolopyrimidine amine, ribose hydroxyls, sul-
famate, and tyrosine (Fig. 5B and fig. S13B),
which underpin the tight binding affinity and
potency. ML901-Tyr is present in the active
sites of both monomers in the dimer (fig. S13,
C, D, J, and K), but differences are observed
with respect to the KMSKS loop, which forms
aflapovertheadenylate/ML901bindingsite
[Fig. 5, B and C(i), and fig. S13, C to F]. In the
B chain, His70 (of 70 HIAQ 73 ) makes close con-
tact with Met248 in the KMSKS loop [Fig. 5C(i)]
and is well defined in the electron density

(fig. S13F). In the A chain, part of the KMSKS
loop is not well defined (fig. S13E), suggesting
that the A chain loop is more mobile, and
His70 adopts a side chainrotamerthatwould
clash with Met248 if the loop was structured
as in chain B (fig. S13, F to I). In combination,
these observations indicate different confor-
mations of the KMSKS loop in individual
monomers within the dimer. By contrast, the
KMSKS loops of both monomers of AMP-
Tyr –boundPf YRS (fig. S14) are well defined,
with the electron density clearly showing
contacts between His70 and Met248 in both
subunits.
In the published structure of tyrosine-bound
HsYRS (PDB: 4QBT) ( 20 ) the equivalent
“KMSSS”loop is not modeled, suggesting
that it is mobile. We were not able to generate
a structure ofHsYRS in complex with enzyme-
generated ML901-Tyr asHsYRS does not cat-
alyze formation of the conjugate. However,
we were able to form crystals ofHsYRS in the
presence of synthetic ML901-Tyr (fig. S15),
consistent with our observation that the pre-
formed conjugate can inhibitHsYRS activity
(fig. S11F). Although we observed clear den-
sity for ML901-Tyr (fig. S15F), the 222 KMSSS 226

Xieet al., Science 376 , 1074–1079 (2022) 3 June 2022 5of6


H49

HsYRS/ML901-Tyr

H70

i) ii) iii)
M248

H70

PfYRS/ML901-Tyr PfYRSS234C/ML901-Tyr

AB

S234
D209
G207

Q210

Q192

I172

Y60

E64

D61
K250

M248

S249

H70

L238 H235

C

Overlay

D

Fig. 5. Structural analysis of YRSs reveals the determinants of potency and
specificity.(A) The structure of the dimericPfYRS/ML901-Tyr complex showing chain
A (green), chain B (blue), and bound ML901-Tyr (red stick representation).
(B) Inhibitor/active site interactions for the B chain. (C)(i)ThePfYRS chain B active
site highlighting the“HIGH”( 70 HIAQ 73 ; light purple) and“KMSKS”( 247 KMSKS 251 ;
light brown) motifs with bound ML901-Tyr (colored by atom type). M248 and
H70 are positioned to interact. (ii) Active site ofHsYRS with bound ML901-Tyr


highlighting the“HIGH”motif ( 49 HVAY 52 ; light pink). (iii) Active site ofPfYRSS234Cwith
bound ML901-Tyr highlighting the“HIGH”( 70 HIAQ 73 ; light green). Unmodelled loops
are shown in [C(ii)] and [C(iii)] as dashed lines. (D)OverlayofPfYRS (B chain),HsYRS,
andPfYRSS234Cshowing the different configurations adopted by His70/His49.Pf YRS
His70, purple;HsYRS His49, pink;Pf YRSS234CHis70, green. Single-letter abbreviations for the
amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K,
Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.

RESEARCH | RESEARCH ARTICLE

Free download pdf